Responses of FEV6, FVC, and FET to inhaled bronchodilator in the adult general population

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Kainu, Annette ^a   Lindqvist, Ari ^a,b   Sarna, Seppo ^c   Lundbäck, Bo ^d   Sovijärvi, Anssi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Clinical Research Institute Ltd   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; BRONCHODILATATION; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MALE; POPULATION; SPIROMETRY; BRONCHUS; DRUG EFFECT; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SMOKING; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; AGED; BRONCHI; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SMOKING; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 70249147651     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-71     Document Type: Article

References (40)

1. Ferguson GT, Enright PL, Buist AS, Higgins MW. National Lung Health Education Program (NLHEP). Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000, 117:1146-1161. 10.1378/chest.117.4.1146, 10767253.
2. Swanney MP, Jensen RL, Crichton DA, Beckert LE, Cardno LA, Crapo RO. FEV6 is an Acceptable Surrogate for FVC in the Spirometric Diagnosis of Airway Obstruction and Restriction. Am J Respir Crit Care Med 2000, 162:917-919.
3. Enright PL, Connett JE, Bailey WC. The FEV1/FEV6 predicts lung function decline in adult smokers. Respiratory Medicine 2002, 96:444-449. 10.1053/rmed.2001.1270, 12117045.
4. Akpinar-Elci M, Fedan KB, Enright PL. FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J 2006, 27:374-7. 10.1183/09031936.06.00081305, 16452595.
5. Hankinson JL, Crapo RO, Jensen RL. Spirometric Reference Values for the 6-s FVC Maneuver. Chest 2003, 124:1805-1811. 10.1378/chest.124.5.1805, 14605052.
6. Garcia-Rio F, Pino JM, Dorgham A, Alonso A, Villamor J. Spirometric reference equations for European females and males aged 65-85 yrs. Eur Respir J 2004, 24:397-405. 10.1183/09031936.04.00088403, 15358698.
7. Hansen JE, Sun X-G, Wasserman K. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?. Eur Respir J 2006, 27:1244-1250. 10.1183/09031936.06.00136905, 16455822.
8. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W. FEV1/FEV6 and FEV6 as an Alternative for FEV1/FVC and FVC in the Spirometric Detection of Airway Obstruction and Restriction. Chest 2005, 127:1560-1564. 10.1378/chest.127.5.1560, 15888828.
9. Vandevoorde J, Verbanck S, Schuermans D, Broekaert L, Devroey D, Kartounian J, Vincken W. Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity. Eur Respir J 2008, 31:391-395. 10.1183/09031936.00032307, 17928313.
10. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriquez-Roisin R, van Weel C, Zielinski J. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
11. Schermer T, Heijdra Y, Zadel S, Bemt L, Boonman-de Winter L, Dekhuijzen R, Smeele I. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 2007, 101:1355-1362. 10.1016/j.rmed.2006.09.024, 17098407.
12. Cerveri I, Pellegrino R, Dore R, Corsico A, Fulgoni P, Woestijne KP, Brusasco V. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol 2000, 88:1989-1995.
13. Girard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilator?. Chest 1983, 84:87-89. 10.1378/chest.84.1.87, 6861550.
14. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968. 10.1183/09031936.05.00035205, 16264058.
15. Kainu A, Lindqvist A, Sarna S, Lundbäck B, Sovijärvi A. FEV1 response to bronchodilation in an adult urban population and in healthy adults. Chest 2008, 134:387-393. 10.1378/chest.07-2207, 18403671.
16. Kainu A, Lindqvist A, Sarna S, Sovijärvi A. Intra-session repeatability of FET and FEV6 in the general population. Clin Phys Funct Imag 2008, 28:196-201. 10.1111/j.1475-097X.2008.00792.x, 18355346.
17. Jensen RL, Crapo RO, Enright P, . Others From the Family Heart Study A Statistical Rationale for the Use of Forced Expiratory Volume in 6s. Chest 2006, 130:1650-1656. 10.1378/chest.130.6.1650, 17166978, Others From the Family Heart Study.
18. Light RW, Conrad SA, George RB. The one best test for evaluating the effects of bronchodilator therapy. Chest 1977, 72:512-516. 10.1378/chest.72.4.512, 908220.
19. Pallasaho P, Rönmark E, Haahtela T, Sovijärvi ARA, Lundbäck B. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp All 2006, 36:503-509. 10.1111/j.1365-2222.2006.02460.x, 16630156.
20. Kainu A. Spirometric studies on the adult general population of Helsinki-bronchodilation responses, determinants, and intrasession repeatability of FEV1, FEV6, FVC, and forced expiratory time A report from the FinEsS-Helsinki II study. University of Helsinki Thesis 2008, 84-98.
21. Lundbäck B. Asthma, chronic bronchitis and respiratory symptoms: prevalence and important determinants. The Obstructive Lung Disease in Northern Sweden Study I. Umeå University Medical Dissertations 1993, 387:1-118. Appendix: i-xii.
22. American Thoracic Society Standardisation of Spirometry. 1994 Update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
23. Quanjer Ph H, Tammeling GJ, Coters JE, Pedersen OF, Peslin R, Yernault J-C. Lung Volumes and Forced Ventilatory Flows. Report Working Party. Official Statement of the European Respiratory Society. Eur Respir J 1993, 6(Suppl 16):5-40.
24. Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest 1982, 42:5-20. 6957974.
25. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Series "ATS/ERS Task Force: Standardisation of Lung Function Testing". Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
26. Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin 1979, 86:420-428. 10.1037/0033-2909.86.2.420, 18839484.
27. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychological Methods 1996, 1:30-46.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i:307-310. 2868172.
29. Chinn S. Repeatability and method comparison. Statistics in respiratory medicine. Thorax 1991, 46:454-456. 463197, 1858087, 10.1136/thx.46.6.454.
30. Ramsdell JW, Tisi GM. Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes. Chest 1979, 76:622-628. 10.1378/chest.76.6.622, 510000.
31. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002, 121:1042-1050. 10.1378/chest.121.4.1042, 11948031.
32. Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998, 114:1607-1612. 10.1378/chest.114.6.1607, 9872196.
33. Tsai AG, Christie JD, Gaughan CA, Palma WR, Margolis ML. Change in Forced Expiratory Time and Spirometric Performance During a Single Pulmonary Function Testing Session. Respir Care 2006, 51:246-251.
34. Tweeddale PM, Alexander F, McHardy GJR. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987, 42:487-490. 460802, 3438892, 10.1136/thx.42.7.487.
35. Cochrane GM, Prieto F, Clark TJH. Intrasubject variability of maximal expiratory flow volume curve. Thorax 1977, 32:171-176. 470560, 867329, 10.1136/thx.32.2.171.
36. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spirometric indices. What is significant?. Chest 1981, 80:97-99. 10.1378/chest.80.1.97, 7249720.
37. Fairshter RD, Wilson AF. Response to inhaled metaproterenol and isoproterenol in asthmatic and normal subjects. Chest 1980, 78:44-50. 10.1378/chest.78.1.44, 7471844.
38. Enright PL, Beck KC, Sherrill DL. Repeatability of spirometry in 18,000 adult patients. Am J Respir Crit Care Med 2004, 169:235-238. 10.1164/rccm.200204-347OC, 14604836.
39. Leith DE, Mead J. Mechanisms determining residual volume of the lungs in normal subjects. J Appl Physiol 1967, 23:221-227.
40. Vandevoorde J, Swanney M. Is forced expiratory volume in six seconds a valid alternative to forced vital capacity? [Letter]. Eur Respir J 2006, 28:1288-1289. 10.1183/09031936.00100206, 17138690.